Search Results - "Mfopou, Josué Kunjom"
-
1
Efficient definitive endoderm induction from mouse embryonic stem cell adherent cultures: A rapid screening model for differentiation studies
Published in Stem cell research (01-01-2014)“…Definitive endoderm (DE) differentiation from mouse embryonic stem cell (mESC) monolayer cultures has been limited by poor cell survival or low efficiency…”
Get full text
Journal Article -
2
Noggin, Retinoids, and Fibroblast Growth Factor Regulate Hepatic or Pancreatic Fate of Human Embryonic Stem Cells
Published in Gastroenterology (New York, N.Y. 1943) (01-06-2010)“…Background & Aims New sources of β cells are needed to develop cell therapies for patients with diabetes. An in vitro, sequential method has been developed to…”
Get full text
Journal Article -
3
Recent Advances and Prospects in the Differentiation of Pancreatic Cells From Human Embryonic Stem Cells
Published in Diabetes (New York, N.Y.) (01-09-2010)“…Recent studies with human embryonic stem (hES) cells have established new protocols for substantial generation of pancreatic progenitors from definitive…”
Get full text
Journal Article -
4
Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the JAK‐STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model
Published in British journal of haematology (01-12-2014)“…Summary Tumour pathogenesis in multiple myeloma (MM) correlates with a high vascular index. Therefore, targeting angiogenesis is an important therapeutic tool…”
Get full text
Journal Article -
5
Role of BMP Signaling in Pancreatic Progenitor Differentiation from Human Embryonic Stem Cells
Published in Stem cell reviews (01-10-2013)“…Transplantation of pancreatic progenitors derived from human embryonic stem cells (hESCs) is a promising way to treat diabetes. Strategies to obtain the…”
Get full text
Journal Article -
6
The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants
Published in Clinical pharmacokinetics (01-10-2021)“…Background and Objective Lorlatinib is a third-generation tyrosine kinase inhibitor approved for the second-line treatment of patients with advanced anaplastic…”
Get full text
Journal Article -
7
Differentiation of pluripotent stem cells into pancreatic lineages
Published in M.S. Médecine sciences (01-08-2013)“…Diabetes mellitus is the leading metabolic disease and represents a major public health concern worldwide. Whereas the transplantation of pancreas…”
Get more information
Journal Article -
8
First-in-Human Phase 1a Study of the Safety, Pharmacokinetics, and Pharmacodynamics of the Noncovalent Bruton Tyrosine Kinase (BTK) Inhibitor SNS-062 in Healthy Subjects
Published in Blood (02-12-2016)“…Background: SNS-062 is a potent, noncovalent (reversible) BTK inhibitor in development for B-cell malignancies and other cancers. SNS-062 has the potential for…”
Get full text
Journal Article -
9
Recent advances and prospects in the differentiation of pancreatic cells from human embryonic stem cells.(PERSPECTIVES IN DIABETES)
Published in Diabetes (New York, N.Y.) (01-09-2010)“…Recent studies with human embryonic stem (hES) cells have established new protocols for substantial generation of pancreatic progenitors from definitive…”
Get full text
Journal Article